<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:48:28Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8502096" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8502096</identifier>
        <datestamp>2021-10-12</datestamp>
        <setSpec>phenaturepg</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Neural Comput Appl</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neural Comput Appl</journal-id>
              <journal-title-group>
                <journal-title>Neural Computing &amp; Applications</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0941-0643</issn>
              <issn pub-type="epub">1433-3058</issn>
              <publisher>
                <publisher-name>Springer London</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8502096</article-id>
              <article-id pub-id-type="pmcid">PMC8502096</article-id>
              <article-id pub-id-type="pmc-uid">8502096</article-id>
              <article-id pub-id-type="pmid">34658535</article-id>
              <article-id pub-id-type="publisher-id">6579</article-id>
              <article-id pub-id-type="doi">10.1007/s00521-021-06579-2</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>S.I. : Neural Computing for IOT based Intelligent Healthcare Systems</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A simulated measurement for COVID-19 pandemic using the effective reproductive number on an empirical portion of population: epidemiological models</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
                  <name>
                    <surname>Alsinglawi</surname>
                    <given-names>Belal</given-names>
                  </name>
                  <address>
                    <email>b.alsinglawi@westernsydney.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Mubin</surname>
                    <given-names>Omar</given-names>
                  </name>
                  <address>
                    <email>o.mubin@westernsydney.edu.au</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alnajjar</surname>
                    <given-names>Fady</given-names>
                  </name>
                  <address>
                    <email>fady.alnajjar@uaeu.ac.ae</email>
                  </address>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kheirallah</surname>
                    <given-names>Khalid</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Elkhodr</surname>
                    <given-names>Mahmoud</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Al Zobbi</surname>
                    <given-names>Mohammed</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Novoa</surname>
                    <given-names>Mauricio</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Arsalan</surname>
                    <given-names>Mudassar</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Poly</surname>
                    <given-names>Tahmina Nasrin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gochoo</surname>
                    <given-names>Munkhjargal</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Khan</surname>
                    <given-names>Gulfaraz</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dev</surname>
                    <given-names>Kapal</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.1029.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9939 5719</institution-id><institution>School of Computer, Data and Mathematical Sciences, </institution><institution>Western Sydney University, </institution></institution-wrap>Rydalmere, NSW 2116 Australia </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.43519.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 6666</institution-id><institution>College of Information Technology, </institution><institution>United Arab Emirates University, </institution></institution-wrap>Al Ain, UAE </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.37553.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 0097 5797</institution-id><institution>Department of Public Health, </institution><institution>Medical School of Jordan University of Science and Technology, </institution></institution-wrap>Irbid, Jordan </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.1023.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 0854</institution-id><institution>School of Engineering and Technology, </institution><institution>Central Queensland University, </institution></institution-wrap>Rockhampton, Queensland Australia </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.1029.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9939 5719</institution-id><institution>School of Built Environment, </institution><institution>Western Sydney University, </institution></institution-wrap>Rydalmere, NSW 2116 Australia </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.412896.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9337 0481</institution-id><institution>College of Medical Science and Technology, </institution><institution>Taipei Medical University, </institution></institution-wrap>Taipei, 101 Taiwan </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.43519.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2193 6666</institution-id><institution>College of Medicine and Health Sciences, </institution><institution>United Arab Emirates University, </institution></institution-wrap>Al Ain, UAE </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.412988.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0109 131X</institution-id><institution>Department of Institute of Intelligent Systems, </institution><institution>University of Johannesburg, </institution></institution-wrap>Johannesburg, South Africa </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>9</day>
                <month>10</month>
                <year>2021</year>
              </pub-date>
              <fpage>1</fpage>
              <lpage>9</lpage>
              <history>
                <date date-type="received">
                  <day>7</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>21</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature 2021</copyright-statement>
                <license>
                  <license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <p id="Par1">COVID-19 as a global pandemic has had an unprecedented impact on the entire world. Projecting the future spread of the virus in relation to its characteristics for a specific suite of countries against a temporal trend can provide public health guidance to governments and organizations. Therefore, this paper presented an epidemiological comparison of the traditional SEIR model with an extended and modified version of the same model by splitting the infected compartment into asymptomatic mild and symptomatic severe. We then exposed our derived layered model into two distinct case studies with variations in mitigation strategies and non-pharmaceutical interventions (NPIs) as a matter of benchmarking and comparison. We focused on exploring the United Arab Emirates (a small yet urban centre (where clear sequential stages NPIs were implemented). Further, we concentrated on extending the models by utilizing the effective reproductive number (<italic>R</italic><sub>t</sub>) estimated against time, a more realistic than the static <italic>R</italic><sub>0</sub>, to assess the potential impact of NPIs within each case study. Compared to the traditional SEIR model, the results supported the modified model as being more sensitive in terms of peaks of simulated cases and flattening determinations.</p>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>COVID-19</kwd>
                <kwd>Simulation</kwd>
                <kwd>SEIR</kwd>
                <kwd>Epidemiologic methods</kwd>
                <kwd>Outbreak</kwd>
                <kwd>Effective reproductive number</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction</title>
              <p id="Par2">Starting in 2020, humankind has increasingly suffered from the spread of a new pandemic characterized by acute respiratory and vascular symptoms produced by a novel coronavirus strain known as SARS-CoV-2 [<xref ref-type="bibr" rid="CR1">1</xref>]. The virus, which initially emerged in Wuhan, China, in November 2019 later was considered a full-fledged outbreak before being declared by the World Health Organisation (WHO) as a public health emergency of international concern [<xref ref-type="bibr" rid="CR2">2</xref>] around early 2020. Today, COVID-19 has no known approved vaccine, and no treatment is considered effective. Meanwhile, governments and health institutions need assistance to visualize, simulate and assess effective Non-pharmaceutical interventions ((NPIs) to mitigate this virus’ unpredictable behaviour and control its spread. Modelling techniques allow simulation and prediction of Covid-19 growth trends and guide pre-emption and preparation. However, it is important to properly introduce model parameters to understand the spread pattern of the infection under different mitigation strategies [<xref ref-type="bibr" rid="CR3">3</xref>]. NPIs utilized to mitigate the spread of the COVID-19, such as lockdown strategies, have served as effective input to the simulation and allowed to present a range of multiple output scenarios. We have also observed a range of data mining as well as statistical and mathematical approaches. The Susceptible Exposed Infectious Recovered (SEIR) model is a widely used mathematical technique to evaluate mitigation strategies and NPI measures [<xref ref-type="bibr" rid="CR4">4</xref>]. The SEIR model relies on various disease outbreak parameters, which the scientific community understands much better now than at the earlier stage of the COVID-19 pandemic.</p>
              <p id="Par3">Furthermore, the model represents various categories of symptomatic levels, providing a more accurate simulation of the pandemic. Prior work in mathematical modelling has shown the implementation of SEIR for specific regions and its ability to be modified to model-specific research aims or scenarios, such as in [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. In work presented in [<xref ref-type="bibr" rid="CR7">7</xref>], the authors discussed a range of parameters that can be introduced to model COVID-19 and improve the accuracy of SEIR models, as applied to eight countries. We also noted the explicit application of SEIR modelling to specific countries. As an example, in [<xref ref-type="bibr" rid="CR8">8</xref>], for the case of China, a layer of quarantined patients was incorporated, as well as those who had passed away, ultimately allowing a prediction of peaks in various regions of China. In [<xref ref-type="bibr" rid="CR31">31</xref>], the SEIR model was modified to include domestic passenger movement data to predict the epidemic's peak. In [<xref ref-type="bibr" rid="CR9">9</xref>], the conventional SEIR model was applied to various social distancing mitigation strategies, where the sustained application of NPIs was able to mitigate the spread of COVID-19 infection. SEIR modelling was also applied to project the health infrastructure needs, such as ICU beds and hospitalization needs, in France [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
              <p id="Par4">In this work, we report on how the effect of NPI measures can be investigated and compared according to the change of effective reproductive number (<italic>R</italic><sub>t</sub>) using simulation techniques. A case study was selected for simulation from the United Arab Emirates (UAE). The UAE case represents a growing urban centre with a highly social and mobile society that has slowly exited its lockdown strategies after an initial outbreak of COVID-19 [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. It is also a multi-cultural nation with a diverse diaspora, two major air transport hubs and a high standard of living. Therefore, the UAE deserves individual focus concerning the potential spread of COVID-19 since it can provide valuable insight to other similar countries. We acknowledge that previous work already discussed NPI measures undertaken by South Asian and Gulf countries to mitigate the spread of COVID-19. However, those lack meaningful modelling results [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
              <p id="Par5">In sum, the case study of the United Arab Emirates was chosen due to the following clear differential aspects. UAE had gradually relaxed its lockdown strategies (such as reopening of international flights as soon as possible). Secondly, most of the interventions for UAE were not publicly available in a clear chronological form to the authors, for example, via the governmental web-sites. Recent research reported that the primary information source for health care workers in the UAE is social media [<xref ref-type="bibr" rid="CR14">14</xref>] and not authentic governmental sources [<xref ref-type="bibr" rid="CR15">15</xref>]. We note that the utilization of the UAE case study allows us to judge the suitability and sensitivity of our proposed model to capture intervention settings and scenarios. The application of these simulation models was further considered by the availability of information regarding mitigation strategies for each country. As stated in the case of UAE, no clear or segmented mitigation strategies were available to the authorship team to guide the model simulation inputs. As such, this provided further evidence of the impact of disclosing and inputting mitigation strategies on simulating COVID-19 spread within different populations. To reiterate, our study aims to provide future forecasting estimations about the spread of COVID-19 in the UAE with different scenarios using the SEIR models. Specifically, we introduce two additional layers by splitting infectious into asymptomatic/symptomatic mild and symptomatic severe. This discretion is integral for the study of COVID-19 spread because it is established that many patients can go untested due to no visible symptoms. However, the virus can transmit from such patients and many patients diagnosed show mild symptoms [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <p id="Par6">A country-based case study was simulated in the current research. The UAE case study evaluated the effects of NPIs when clear policies are neither publicly communicated nor publicly available.</p>
              <sec id="Sec3">
                <title>Model description and parameters</title>
                <p id="Par7">A simulated compartmental model was implemented to measure the spread of COVID-19 using an empirical population sample (across both case studies). Our simulated model is built upon an extended version of the SEIR Model [<xref ref-type="bibr" rid="CR17">17</xref>]. We have used a portion of the UAE population (2,998,325) which is the total empirical population sample in GleamViz software in this study into 5 compartmental state: Susceptible (<italic>S</italic>), Exposed (<italic>E</italic>), Infected Asymptomatic-mild (<italic>I</italic><sub><italic>a</italic></sub>), Infected Symptomatic Severe (<italic>I</italic><sub>s</sub>) and Recovered (<italic>R</italic>). The constant <italic>N</italic> (<italic>N</italic> = <italic>S</italic> + <italic>E</italic> + <italic>I</italic><sub><italic>a</italic></sub>+ <italic>I</italic><sub>s</sub> + <italic>R</italic>) denotes the total population (<italic>N </italic>= 2,998,325 for UAE (S1). The categories of the compartments are further described below.<list list-type="bullet"><list-item><p id="Par8"><italic>Susceptible (S)</italic> All non-immune susceptible empirical population samples in our study.</p></list-item><list-item><p id="Par9"><italic>Exposed (E)</italic> latent but not yet infectious or “have no symptoms, and they cannot spread the virus yet”.</p></list-item><list-item><p id="Par10"><italic>Infected asymptomatic-symptomatic mild (I</italic><sub><italic>a</italic></sub><italic>)</italic> Refers to transmission of the virus from a person who does not develop symptoms or with mild symptoms [<xref ref-type="bibr" rid="CR18">18</xref>] to another person (not yet latent but suspected).</p></list-item><list-item><p id="Par11"><italic>Infected symptomatic severe (I</italic><sub><italic>s</italic></sub><italic>)</italic> The state of COVID-19 infection can progress to severe disease with dyspnoea and severe chest symptoms [<xref ref-type="bibr" rid="CR19">19</xref>].</p></list-item><list-item><p id="Par12"><italic>Recovered (R)</italic> Population showing immunity for COVID-19 after infection recovery.</p></list-item></list></p>
                <p id="Par13">In the course of many diseases, there are an unknown fraction of the in-infected hosts that are still able to spread the disease while remaining symptoms-free (asymptomatic) [<xref ref-type="bibr" rid="CR20">20</xref>]. In our model, asymptomatic cases are combined with mild cases in the same fraction. This confirms the reported proportion of the infections according to WHO [<xref ref-type="bibr" rid="CR18">18</xref>]. Rationally, splitting the asymptomatic and mild into <italic>I</italic><sub>a</sub> compartmental state and the symptomatic severe into Is compartmental state and the understanding of spreading growth for each compartment are a worthwhile attempt. Further, it is deemed as an important research task to evaluate the behaviour of each compartment in the pandemic event and for further compartments evaluation in relation to the NPI mitigation strategies such as social distancing, lockdown, wearing masks, and more strategies arise as the pandemic progress (which reinforces our aim to apply the modelled simulation to two distinct case studies). Therefore, our proposed epidemiological model is espousing the asymptomatic mild and severe states according to the WHO new classification [<xref ref-type="bibr" rid="CR18">18</xref>] for COVID-19 infected cases. The (beta) time-based(t) (<italic>β</italic><sub>t</sub>) describes the transmission rate (vary according to social distancing, remote working, closing schools, wearing masks, etc.). Alpha (<italic>α</italic>) indicates the reduction in the transmission rate of <italic>β</italic> in the isolated infectious symptomatic (severe), where patients are isolated [<xref ref-type="bibr" rid="CR21">21</xref>]. The incubation period (<italic>γ</italic>) is a period from the state of the exposure to the disease to become in-infectious. Our model used the value of (<italic>γ</italic> = 1/5.2 ‘days’) [<xref ref-type="bibr" rid="CR22">22</xref>]. The recovery rate (<italic>µ</italic>) in our model indicates the time until an infectious case is recovered. Previous research [<xref ref-type="bibr" rid="CR12">12</xref>] tells us the recovery time for COVID-19 is 14 days. We have used this value (recovery rate is (<italic>µ</italic> = 1/14 days) in our model. More information regarding the parameters used in our study is discussed in Table <xref rid="Tab1" ref-type="table">1</xref>. The COVID-19 pandemic transmission in our model can be described by:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{S} = - \beta_{{\text{t}}} S(I_{{\text{a}}} + I_{{\text{s}}} ) $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mtext>s</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{E} = \beta_{{\text{t}}} S(I_{{\text{a}}} + I_{{\text{s}}} ) - \gamma E $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mtext>s</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{I}_{{\text{a}}} = \gamma P_{{\text{a}}} E - \mu I_{{\text{a}}} $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mtext>a</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mi>E</mml:mi><mml:mo>-</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mtext>a</mml:mtext></mml:msub></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{I}_{{\text{s}}} = \gamma (1 - P_{{\text{a}}} )E - \mu I_{{\text{s}}} $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mtext>s</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>E</mml:mi><mml:mo>-</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mtext>s</mml:mtext></mml:msub></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{R} = \mu I_{{\text{a}}} + \mu I_{{\text{s}}} $$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mtext>s</mml:mtext></mml:msub></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>where <italic>N</italic> = <italic>S</italic> + <italic>E</italic> + <italic>I</italic><sub>a</sub> + <italic>I</italic><sub>s</sub> + <italic>R</italic>. We have calculated the beta<sub>(t)</sub> (<italic>β</italic><sub>t</sub>) according to equation (<xref rid="Equ6" ref-type="">6</xref>):<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \beta_{{\text{t}}} = R_{{\text{t}}} \mu /P_{{\text{a}}} \alpha + (1 - P_{{\text{a}}} ) $$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mi>μ</mml:mi><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mtext>a</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>We proposed model on the basis of SEIR Model [<xref ref-type="bibr" rid="CR4">4</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The traditional SEIR model equation is formed as the following:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{S} = - \beta tSI $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>S</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:mi>t</mml:mi><mml:mi>S</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{E} = \beta tSI - \gamma E $$\end{document}</tex-math><mml:math id="M16" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>E</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mi>t</mml:mi><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mi>E</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{I} = \gamma E - \mu I $$\end{document}</tex-math><mml:math id="M18" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>I</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>γ</mml:mi><mml:mi>E</mml:mi><mml:mo>-</mml:mo><mml:mi>μ</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \dot{R} = \mu I $$\end{document}</tex-math><mml:math id="M20" display="block"><mml:mrow><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula>where <italic>N </italic>= <italic>S </italic>+<italic> E </italic>+<italic> I</italic> + <italic>R</italic>. Figure <xref rid="Fig1" ref-type="fig">1</xref> represents the traditional compartments for the SEIR model. The beta<sub>(t)</sub> (<italic>β</italic><sub>t</sub>) is time-dependent. Therefore, (<italic>β</italic><sub>t</sub>) is denoted with the following equation:<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \beta_{{\text{t}}} = R_{{\text{t}}} \mu $$\end{document}</tex-math><mml:math id="M22" display="block"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>t</mml:mtext></mml:msub><mml:mi>μ</mml:mi></mml:mrow></mml:math><graphic xlink:href="521_2021_6579_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula>Figures <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref> compare the dissimilarity between (<italic>I</italic><sub>a</sub> and <italic>I</italic><sub>s</sub>) compartments of (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) to the infected compartment (<italic>I</italic>) in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Equations (<xref rid="Equ1" ref-type="">1</xref>–<xref rid="Equ6" ref-type="">6</xref>) are the COVID-19 transmission equations of (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) in contrast with SEIR Eqs. (<xref rid="Equ7" ref-type="">7</xref>–<xref rid="Equ11" ref-type="">11</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Model parameters and description</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Description</th><th align="left">Value(s) and Ref</th></tr></thead><tbody><tr><td align="left"><italic>γ</italic></td><td align="left">The incubation period from the state of exposure to the disease to become infectious for S1</td><td align="left">5.2 days [<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td align="left">Pa</td><td align="left">Probability of being asymptomatic–symptomatic (Mild)</td><td align="left">0.8 [<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td align="left">Ps</td><td align="left">Probability of being severe symptomatic requiring hospitalization = (<bold>1</bold> − <italic>Pa</italic>)</td><td align="left">0.2 [<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td align="left"><italic>β</italic><sub>t</sub></td><td align="left">Beta(<italic>t</italic>) or transmission rate describes the spread of disease in the community</td><td align="left">Equation 6 for S1 and Eq. 11 for S1 (given above)</td></tr><tr><td align="left"><italic>α</italic></td><td align="left">Alpha: reduction in transmission rate (severe)</td><td align="left">0.5 [<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left"><italic>µ</italic></td><td align="left">The recovery rate for (S1): Indicates the time until the infectious case becomes re-covered</td><td align="left">14 days [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] <italic>µ</italic> (1/14 days = 0.07 “day<sup><italic>−</italic>1</sup>”)</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>SEIR model</p></caption><graphic xlink:href="521_2021_6579_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Architecture of the proposed SEI<sub><italic>a</italic></sub>I<sub><italic>s</italic></sub>R model (S1)</p></caption><graphic xlink:href="521_2021_6579_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec4">
                <title>Estimating the effective reproductive number</title>
                <p id="Par14">The <italic>R</italic><sub>t</sub> (effective reproductive number) measures the transmission potential of COVID-19, which is also referred to as the average number of people who will catch the disease from a single infected individual. When the pandemic occurs, the effective reproductive number <italic>R</italic><sub>t</sub> measures which will become in-infected per infectious person at a time (t). The most well-known version of <italic>R</italic><sub>t</sub> is the basic reproductive number <italic>R</italic><sub>0</sub>. However, the <italic>R</italic><sub>0</sub> is a single measure that does not reflect changes in disease transmission, behaviours and restrictions in communities over time. Alternatively, as the pandemic progresses, mitigation strategies could be tightened, more restrictions imposed, or relaxed. This enables <italic>R</italic><sub>t</sub> to vary over time. Therefore, the <italic>R</italic><sub>t</sub> value is subject to variation after or before the introduction of NPIs. To estimate the <italic>R</italic><sub>t</sub>, we have used a real-time Bayesian estimation [<xref ref-type="bibr" rid="CR24">24</xref>] and implementation of work by [<xref ref-type="bibr" rid="CR25">25</xref>]. Figure <xref rid="Fig3" ref-type="fig">3</xref> in the results and discussion section provides the calculated <italic>R</italic><sub>t</sub> values for UAE with a value of 2.4. Modelling software we have utilized is GLEAMviz client simulator [<xref ref-type="bibr" rid="CR26">26</xref>], which combines world data such as countries populations and human mobility. The GLEAMviz simulator elaborates compartmental stochastic models [<xref ref-type="bibr" rid="CR27">27</xref>] for disease transmission in a global epidemic event. To forecast the number of estimated future compartments for the COVID-19 epidemic in the UAE, we have exploited a previous model, “Global Epidemic and Mobility GLEaM H1N1 schematic” [<xref ref-type="bibr" rid="CR26">26</xref>] depicts the spread of such as an epidemic disease. We considerably modified the model to include the compartment of asymptomatic mild and symptomatic severe layers. Noting that <italic>I</italic><sub>a</sub> represents the asymptomatic mild cohort and the <italic>I</italic><sub>s</sub> represents the symptomatic severe cohort in the study. Figure <xref rid="Fig2" ref-type="fig">2</xref> represents the schematic for our proposed epidemiological model compartments.<fig id="Fig3"><label>Fig. 3</label><caption><p>Real-time <italic>R</italic><sub>t</sub> for UAE from 23/3/2020 to 2/8/2020</p></caption><graphic xlink:href="521_2021_6579_Fig3_HTML" id="MO3"/></fig></p>
              </sec>
            </sec>
            <sec id="Sec5">
              <title>Results and discussion</title>
              <p id="Par15">Currently, there is no cure or effective vaccine for Covid-19 while the pandemic continues to spread, and there are more daily confirmed positive cases and deaths recorded worldwide. Aptly, it is necessary to maintain and measure NPIs effectiveness and figure out how to flatten the pandemic curve with long term interventions until the time that successful vaccines are widely available or effective treatment is available. This section reflects on findings from the UAE case study, particularly where detailed NPIs are not publicly available. Our model is sensitive to the contact rate t that determines the change of the <italic>R</italic><sub>t</sub> value, which is the essential entry to our simulation to reflect the policy outcomes in real-time <italic>R</italic><sub>t</sub> measurement. The GLEAMviz simulation was run to initialize the spread of COVID-19 in the UAE starting on the 29th of January 2020. Since the GleamViz is limited to 365 days, our simulation ends on 28/1/2021 for UAE. Then, we simulated our proposed model <italic>SEI</italic><sub>a</sub><italic>I</italic><sub>s</sub><italic>R</italic> (S1) for the situation of UAE. After that, we demonstrated the results of the S1 simulation on an empirical portion of the population of the UAE. The S1 simulation considered the changes in the <italic>R</italic><sub>t</sub> according to the changes (tightening or easing) in policies in UAE, between 29/1/2020 and 2/8/2020. The data used to calculate the <italic>R</italic><sub>t</sub> were fetched from the Github repository of “Our World in Data” [<xref ref-type="bibr" rid="CR28">28</xref>] for the UAE case. Furthermore, the data preprocessing step was applied to get the daily new cases from the John Hopkins official Github. The data attributes are the date, name of the country and the number of new daily cases (k) for the UAE. This step is essential in measuring <italic>R</italic><sub>t</sub> [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. We have decided to change <italic>R</italic><sub>t</sub> for simulation inputs by 0.5 points of <italic>R</italic><sub>t</sub> each increase in the <italic>R</italic><sub>t</sub> or increment. This is assuming the 0.5 value has a noticeable impact on the simulation results.</p>
              <sec id="Sec6">
                <title>COVID-19 simulation in undisclosed public health strategy for the public (UAE)</title>
                <p id="Par16">Figure <xref rid="Fig3" ref-type="fig">3</xref> shows the real-time <italic>R</italic><sub>t</sub> for UAE. Since UAE went through different levels of social distancing, restrictions and easing of restrictions strategies, estimating the <italic>R</italic><sub>t</sub> is an essential task to measure and reflect the policy outcomes on empirical data of (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) over time. The simulation parameters values (Table <xref rid="Tab1" ref-type="table">1</xref>) are the input for extended SEIR (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) simulation. Our strategy was to update the extended SEIR upon each 0.5 difference in <italic>R</italic><sub>t</sub> value to adopt the changes of a policy at a point of time. We have fed the model with <italic>R</italic><sub>t</sub> values in the GleamViz‘s exception layer, indicating the policy measured at a time (t). Since we were limited to the new COVID-19 daily cases obtained by the Github repository of Our World in Data [<xref ref-type="bibr" rid="CR2">2</xref>], the <italic>R</italic><sub>t</sub> measure started on 23/3/2020. However, we kept the value of R<sub>0</sub> constant from 29/1/2020 until 23/3/2020. We assumed that the <italic>R</italic><sub>0 </sub>= 2.5 in our model based on information from the WHO [<xref ref-type="bibr" rid="CR18">18</xref>] since there was no available data about <italic>R</italic><sub>t</sub> at the beginning of the pandemic.</p>
                <p id="Par17"><italic>R</italic><sub>t</sub> in the UAE fluctuated between zero at the beginning of the pandemic and 3, during the first two weeks of the pandemic. After that, a decline in the <italic>R</italic><sub>t</sub> was noted, reaching around one around the 40th day. Around the 50th day of the pandemic, <italic>R</italic><sub>t</sub> increased to around 2 and declined after that to less than one between the 60th and 90th day of the pandemic. The sharpest decrease in <italic>R</italic><sub>t</sub> was observed between day 110 and 120 of the pandemic. By the end of the simulation, <italic>R</italic><sub>t</sub> was noted as 1.08.</p>
                <p>As of 23/05/2020, the median rate (95% CI) of asymptomatic mild cases was 11.25 (5.62–12.26) per1000 population with a cumulative median of 356.64 (173.07–540.17) per 1000 population (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a). In the severe COVID-19, cases peaked by 20/5/2020 and the simulation predicted that there will be no severe cases after 16/12/2020. The median rate was simulated at 2.83 (1.35–3.02) per 1000 population and a cumulative median of 81.36 (39.02–126.22) per 1000 population, as shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>b. Simulated severe COVID-19 cases are essential to estimate the population that may require advanced health services, critical care services or even hospitalization care. Simulation of severe cases will facilitate estimating the needs for health services and identifying anticipated needs for patients with the severe diagnosis. After that, a simple comparison of estimated numbers and availability of health services will provide a valuable need assessment and identify potential gaps in medical services. However, the lack of healthcare indicators from the UAE limited such comparison and restricted our abilities to anticipate the gap as mentioned above.<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>a</bold>–<bold>c</bold> Median, lower 95%CI, upper 95%CI) for asymptomatic mild, severe and recovered estimated cases (S1)</p></caption><graphic xlink:href="521_2021_6579_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p><bold>a</bold>–<bold>c</bold> Cumulative (median, lower 95%CI, upper 95%CI) for asymptomatic-mild, severe and recovered estimated cases (S1)</p></caption><graphic xlink:href="521_2021_6579_Fig5_HTML" id="MO5"/></fig></p>
                <p id="Par18">Recovered cases in S1 followed the same trends of Asymptomatic-mild and severe cases. Figure <xref rid="Fig4" ref-type="fig">4</xref>c illustrates that the peak median recovered cases reached 12.98 per 1000 (6.92–13.41), and median Cumulative was 418.15(206.55–622.50) per 1000 population, as shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>c. The simulation, according (Fig. <xref rid="Fig2" ref-type="fig">2</xref>), estimated recovered cases to flattened by 27/1/2021. With reference to the flattening of the curve, in general, we observed that our results are in line with prior literature [<xref ref-type="bibr" rid="CR29">29</xref>], where it was shown that lockdown and stringency measures are required to be sustained for anywhere between 3 and 5 months to flatten the curve (albeit for the case of UK). With the increased global concerns of COVID-19, strict NPI measures become necessary to mitigate the risks associated with COVID-19. Citizens’ commitment is critical to control the epidemic.When citizens adapt to the NPI measures, a reduction in the spread of the epidemic is expected. The combined efforts from both governments and citizens are then critical for designing and adapting effective NPI measures. This is reflected in the epidemic curve of the pandemic. In the current study, the effect of NPIs was assessed utilizing <italic>R</italic><sub>t</sub> using advanced simulation models for UAE. The model established potential evidence of effective NPIs to control the spread of COVID-19, especially when model modifications were introduced to meet the characteristics of the pandemic. Adopted NPIs in UAE geographic locations effectively reduced the effective reproduction number below one. Further, the results indicated that the rapid introduction of NPIs has a more effective reduction in the spread of the epidemic.Multiple models evaluated the effectiveness of state measures to control COVID-19 spread. A direct link was established between the effectiveness of NPIs [<xref ref-type="bibr" rid="CR11">11</xref>] on reducing the reproduction rate (R<sub><italic>t</italic></sub>). Our results are in line with the literature. They indicate that effective implementation of NPI measures has potentially profound consequences on the epidemic curve of COVID-19 by reducing the number of newly reported or simulated cases and reducing the effective reproduction number. The message behind such results is a cornerstone for communicating public health policies and the implementation of NPIs. The sensitivity of <italic>R</italic><sub>t</sub> to the contact rate is critical in spreading or containing the spread of COVID-19.The effect of contact rates is, in turn, dependent on NPIs, which then are critical for mitigating the disease. Regardless, our study provides evidence that the effect of NPI measures could be evaluated and discussed using the effective reproductive rate. This is an added value to public health professionals and could be used when designing and implementing mitigation strategies, such as discussing whether suppression or control is more appropriate. On the other hand, traditional SEIR models seem to be limited in assessing the effect of NPI measures on the epidemic curves of COVID-19 [<xref ref-type="bibr" rid="CR30">30</xref>]. This note is directly related to the need to consider the characteristics of the disease, with COVID-19 representing itself uniquely as asymptomatic cases that needed to be fine-tuned when designing the model compartments. Disease severity, therefore, is deemed critical for modelling and simulating the transmission of COVID-19 within populations. Within the uncertainties associated with COVID-19, time will tell if these asymptomatic mild cases are of more significant concern for disease transmission. Regardless, modelling and simulation techniques should consider modifying the traditional SEIR to present the epidemic curve better. A vital research implication of our work is that estimating the proportion of severe cases requiring hospitalization using SEIR extended epidemiological models may help healthcare decision-makers during the pandemics. For instance, hospital healthcare decision-makers such as beds managers, clinicians, and healthcare managers can work more effectively and plan the beds and staffing. Moreover, the healthcare assessments systems such as the clinical decision systems to predict patients' length of stays in ICU or COVID-intensive care units, including ventilators, are utilized. This is an essential task for hospitals to manage beds scarcity, especially in uncertainties such as pandemics.</p>
              </sec>
            </sec>
            <sec id="Sec7">
              <title>Study limitations</title>
              <p id="Par19">Our study provides an interesting outlook on the computation of <italic>R</italic><sub>t</sub> concerning stated interventions; however, there are some limitations also associated with the simulation. Our model is evaluated on empirical population data. We did not examine our model on real confirmed cases due to the lack of many variables necessary for stochastic compartment models. Transmission data may simply not be available or is made private by the authorities, which has ultimately limited our potential to run the model on real-world data and evaluate the predictions of the simulated model against (Asymptomatic-Mild) and real severe cases. We have also assumed that the entire population of the sample country (in our case UAE) is susceptible. Prior work has utilized other ranges, such as 70% [<xref ref-type="bibr" rid="CR23">23</xref>]. Further, we have not executed any complementary logistic modelling on our scenarios for the UAE.Furthermore, we did not study and report the severe cases that require hospitalizations. Therefore, a future study should include forecasting severe cases that may require hospitalizations in the model. Finally, the Glemaviz software application does not allow accessing the mathematical equations used to run the model. This limits our abilities to adjust disease characteristics within the equations. This may be a reason behind discrepancies in S1 and SEIR models. Still, Glemaviz is a user-friendly application that allows public health professionals to run simulation models without an in-depth understanding of advanced mathematical equations.</p>
            </sec>
            <sec id="Sec8">
              <title>Conclusions</title>
              <p id="Par20">Our study attempted to extend the SEIR model by forking the infectious compartment into two subcategories, namely asymptomatic mild or symptomatic severe. We have also illustrated how the effective reproductive number (and its change over time) can be computed using available parameters, despite the lack of realistic data. This computation has allowed us to forecast and predict the outlook of COVID-19 in the UAE as our sample country of an investigation by using the two variations in the SEIR model. Our results show us that the modified SEIR model is more sensitive and can also determine when the diffusion will flatten.We also summarize certain limitations of our modelling; the most concerning is the lack of real empirical data. Nevertheless, with the comfort of prior literature [<xref ref-type="bibr" rid="CR31">31</xref>] where it is highlighted that the SEIR modelling is appropriate for longer-term projections, and it provides a range of parameters for specific contexts, we ascertain that our determinations can drive public health policy in small to mid-size countries such as the UAE. In future work, we will predict hospital length of stay for COVID-19 inpatients admitted into hospital departments such as intensive care unit (ICU) by using the advancement of machine learning models [<xref ref-type="bibr" rid="CR32">32</xref>] and deep neural networks models [<xref ref-type="bibr" rid="CR33">33</xref>] to assist hospital beds managers and clinical practitioners with resources utilizations during the time of uncertainties such as pandemic.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
              <fn>
                <p>Belal Alsinglawi and Omar Mubin are joint first authors.</p>
              </fn>
            </fn-group>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>Not applicable.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and material</title>
              <p>The simulation and the algorithm are available upon request. Please contact the first author of this study, Belal Alsinglawi b.alsinglawi@westernsydney.edu.au; b.alsinglawi@gmail.com.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1" notes-type="COI-statement">
                <title>Conflict of interest</title>
                <p id="Par21">The authors declare that they have no conflict of interest.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ackermann</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Verleden</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Kuehnel</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Haverich</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Welte</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Laenger</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Vanstapel</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Werlein</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Stark</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Tzankov</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19</article-title>
                  <source>New Engl J Med</source>
                  <year>2020</year>
                  <volume>383</volume>
                  <fpage>120</fpage>
                  <lpage>128</lpage>
                  <pub-id pub-id-type="doi">10.1056/NEJMoa2015432</pub-id>
                  <pub-id pub-id-type="pmid">32437596</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brahma</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Chakraborty</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Menokee</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <source>The early days of a global pandemic: A timeline of covid-19 spread and government interventions</source>
                  <year>2020</year>
                  <publisher-loc>Washington, DC</publisher-loc>
                  <publisher-name>Brookings</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <mixed-citation publication-type="other">Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, Wesolowski A, Zhang C, Du X, Yu H (2020) Effect of non-pharmaceutical interventions for containing the covid-19 outbreak: an observational and modelling study. medRxiv</mixed-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Graef</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Karsai</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Global dynamics of a Seir model with varying total population size</article-title>
                  <source>Math Biosci</source>
                  <year>1999</year>
                  <volume>160</volume>
                  <issue>2</issue>
                  <fpage>191</fpage>
                  <lpage>213</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0025-5564(99)00030-9</pub-id>
                  <pub-id pub-id-type="pmid">10472754</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dil</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Dil</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Maken</surname>
                      <given-names>ZH</given-names>
                    </name>
                  </person-group>
                  <article-title>Covid-19 trends and forecast in the eastern mediterranean region with a particular focus on Pakistan</article-title>
                  <source>Cureus</source>
                  <year>2020</year>
                  <volume>12</volume>
                  <issue>6</issue>
                  <fpage>e8582</fpage>
                  <pub-id pub-id-type="pmid">32670717</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Farooq</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bazaz</surname>
                      <given-names>MA</given-names>
                    </name>
                  </person-group>
                  <article-title>A novel adaptive deep learning model of covid-19 with focus on mortality reduction strategies</article-title>
                  <source>Chaos Solitons Fractals</source>
                  <year>2020</year>
                  <volume>138</volume>
                  <fpage>110148</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.chaos.2020.110148</pub-id>
                  <pub-id pub-id-type="pmid">32834586</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <mixed-citation publication-type="other">Zhou X, Ma X, Hong N, Su L, Ma Y, He J, Jiang H, Liu C, Shan G, Zhu W (2020) Forecasting the worldwide spread of covid-19 based on logistic model and seir model. medRxiv</mixed-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <mixed-citation publication-type="other">Peng L, Yang W, Zhang D, Zhuge C, Hong L (2020) Epidemic analysis of covid-19 in china by dynamical modeling</mixed-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Prem</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>TW</given-names>
                    </name>
                    <name>
                      <surname>Kucharski</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Eggo</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Davies</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Flasche</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Clifford</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Pearson</surname>
                      <given-names>CA</given-names>
                    </name>
                    <name>
                      <surname>Munday</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of control strategies to reduce social mixing on outcomes of the covid-19 epidemic in Wuhan, China: a modelling study</article-title>
                  <source>The Lancet Public Health</source>
                  <year>2020</year>
                  <volume>5</volume>
                  <fpage>e261</fpage>
                  <lpage>e270</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30073-6</pub-id>
                  <pub-id pub-id-type="pmid">32220655</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <mixed-citation publication-type="other">Massonnaud C, Roux J, Crépey P (2020) Covid-19: forecasting short term hospital needs in France. medRxiv</mixed-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>AlQutob</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Moonesar</surname>
                      <given-names>IA</given-names>
                    </name>
                    <name>
                      <surname>Tarawneh</surname>
                      <given-names>MR</given-names>
                    </name>
                    <name>
                      <surname>Al Nsour</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Khader</surname>
                      <given-names>Y</given-names>
                    </name>
                  </person-group>
                  <article-title>Public health strategies for the gradual lifting of the public sector lockdown in Jordan and the United Arab Emirates during the covid-19 crisis</article-title>
                  <source>JMIR Public Health Surveill</source>
                  <year>2020</year>
                  <volume>6</volume>
                  <issue>3</issue>
                  <fpage>e20478</fpage>
                  <pub-id pub-id-type="doi">10.2196/20478</pub-id>
                  <pub-id pub-id-type="pmid">32589151</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tang</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Bragazzi</surname>
                      <given-names>NL</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Xiao</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>An updated estimation of the risk of transmission of the novel coronavirus (2019-ncov)</article-title>
                  <source>Infectious Disease Model</source>
                  <year>2020</year>
                  <volume>5</volume>
                  <fpage>248</fpage>
                  <lpage>255</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.idm.2020.02.001</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <mixed-citation publication-type="other">Bloukh SH, Shaikh A, Pathan HM, Edis Z (2020) Prevalence of covid-19: A look behind the scenes from the UAE and India</mixed-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <mixed-citation publication-type="other">Bhagavathula AS, Aldhaleei WA, Rahmani J, Mahabadi MA, Bandari DK (2020) Novel coronavirus (covid-19) knowledge and perceptions: a survey on healthcare workers. MedRxiv</mixed-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Elkhodr</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Mubin</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Iftikhar</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Masood</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Alsinglawi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Shahid</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Alnajjar</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>Technology, privacy, and user opinions of covid-19 mobile apps for contact tracing: Systematic search and content analysis</article-title>
                  <source>J Med Internet Res</source>
                  <year>2021</year>
                  <volume>23</volume>
                  <issue>2</issue>
                  <fpage>e23467</fpage>
                  <pub-id pub-id-type="doi">10.2196/23467</pub-id>
                  <pub-id pub-id-type="pmid">33493125</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cascella</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Rajnik</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Cuomo</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Dulebohn</surname>
                      <given-names>SC</given-names>
                    </name>
                    <name>
                      <surname>Di Napoli</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <source>Features, evaluation and treatment coronavirus (COVID-19)</source>
                  <year>2020</year>
                  <publisher-loc>Treasure Island</publisher-loc>
                  <publisher-name>StatPearls Publishing</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>MY</given-names>
                    </name>
                    <name>
                      <surname>Muldowney</surname>
                      <given-names>JS</given-names>
                    </name>
                  </person-group>
                  <article-title>Global stability for the Seir model in epidemiology</article-title>
                  <source>Math Biosci</source>
                  <year>1995</year>
                  <volume>125</volume>
                  <issue>2</issue>
                  <fpage>155</fpage>
                  <lpage>164</lpage>
                  <pub-id pub-id-type="doi">10.1016/0025-5564(95)92756-5</pub-id>
                  <pub-id pub-id-type="pmid">7881192</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <mixed-citation publication-type="other">Organization WH (2020) Coronavirus disease 2019 (covid-19). Report (2020). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-sitrep-46-covid-19.pdf?sfvrsn=96b04adf4">https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200306-sitrep-46-covid-19.pdf?sfvrsn=96b04adf4</ext-link></mixed-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Velavan</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Meyer</surname>
                      <given-names>CG</given-names>
                    </name>
                  </person-group>
                  <article-title>The covid-19 epidemic</article-title>
                  <source>Trop Med Int Health</source>
                  <year>2020</year>
                  <volume>25</volume>
                  <issue>3</issue>
                  <fpage>278</fpage>
                  <lpage>280</lpage>
                  <pub-id pub-id-type="doi">10.1111/tmi.13383</pub-id>
                  <pub-id pub-id-type="pmid">32052514</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chisholm</surname>
                      <given-names>RH</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>PT</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Tong</surname>
                      <given-names>SY</given-names>
                    </name>
                    <name>
                      <surname>McVernon</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Geard</surname>
                      <given-names>N</given-names>
                    </name>
                  </person-group>
                  <article-title>Implications of asymptomatic carriers for infectious disease transmission and control</article-title>
                  <source>R Soc Open Sci</source>
                  <year>2018</year>
                  <volume>5</volume>
                  <issue>2</issue>
                  <fpage>172341</fpage>
                  <pub-id pub-id-type="doi">10.1098/rsos.172341</pub-id>
                  <pub-id pub-id-type="pmid">29515909</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Verity</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Okell</surname>
                      <given-names>LC</given-names>
                    </name>
                    <name>
                      <surname>Dorigatti</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Winskill</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Whittaker</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Imai</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Cuomo-Dannenburg</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>PG</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>H</given-names>
                    </name>
                  </person-group>
                  <article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>
                  <source>Lancet Infect Dis</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <fpage>669</fpage>
                  <lpage>677</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30243-7</pub-id>
                  <pub-id pub-id-type="pmid">32240634</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Gayle</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Wilder-Smith</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rocklöv</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>The reproductive number of covid- 19 is higher compared to SARS coronavirus</article-title>
                  <source>J Travel Med</source>
                  <year>2020</year>
                  <volume>27</volume>
                  <fpage>taaa021</fpage>
                  <pub-id pub-id-type="doi">10.1093/jtm/taaa021</pub-id>
                  <pub-id pub-id-type="pmid">32052846</pub-id>
                </element-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wölfel</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Corman</surname>
                      <given-names>VM</given-names>
                    </name>
                    <name>
                      <surname>Guggemos</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Seilmaier</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Zange</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Müller</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Niemeyer</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>TC</given-names>
                    </name>
                    <name>
                      <surname>Vollmar</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Rothe</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Virological assessment of hospitalized patients with covid-2019</article-title>
                  <source>Nature</source>
                  <year>2020</year>
                  <volume>581</volume>
                  <issue>7809</issue>
                  <fpage>465</fpage>
                  <lpage>469</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-020-2196-x</pub-id>
                  <pub-id pub-id-type="pmid">32235945</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bettencourt</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Ribeiro</surname>
                      <given-names>RM</given-names>
                    </name>
                  </person-group>
                  <article-title>Real time Bayesian estimation of the epidemic potential of emerging infectious diseases</article-title>
                  <source>PLoS ONE</source>
                  <year>2008</year>
                  <volume>3</volume>
                  <issue>5</issue>
                  <fpage>e2185</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0002185</pub-id>
                  <pub-id pub-id-type="pmid">18478118</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <mixed-citation publication-type="other">(2020) <ext-link ext-link-type="uri" xlink:href="https://www.datacamp.com/community/tutorials/replicating-in-r-covid19">https://www.datacamp.com/community/tutorials/replicating-in-r-covid19</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Balcan</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Goncalves</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Bajardi</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Poletto</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ramasco</surname>
                      <given-names>JJ</given-names>
                    </name>
                    <name>
                      <surname>Paolotti</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Perra</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Tizzoni</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Van den Broeck</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Seasonal transmission potential and activity peaks of the new influenza a (h1n1): a monte carlo likelihood analysis based on human mobility</article-title>
                  <source>BMC Med</source>
                  <year>2009</year>
                  <volume>7</volume>
                  <issue>1</issue>
                  <fpage>45</fpage>
                  <pub-id pub-id-type="doi">10.1186/1741-7015-7-45</pub-id>
                  <pub-id pub-id-type="pmid">19744314</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <mixed-citation publication-type="other">Greenwood, P.E., Gordillo, L.F.: Stochastic epidemic modeling, pp. 31–52. Springer, Berlin (2009)</mixed-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <mixed-citation publication-type="other">(2020). <ext-link ext-link-type="uri" xlink:href="https://github.com/owid/covid-19-data/tree/master/public/data">https://github.com/owid/covid-19-data/tree/master/public/data</ext-link></mixed-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Laydon</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Nedjati Gilani</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Imai</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Ainslie</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Baguelin</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Bhatia</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Boonyasiri</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cucunuba Perez</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Cuomo-Dannenburg</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce covid19 mortality and healthcare demand</article-title>
                  <source>Imperial College Lond</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <fpage>491</fpage>
                  <lpage>497</lpage>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kheirallah</surname>
                      <given-names>KA</given-names>
                    </name>
                    <name>
                      <surname>Alsinglawi</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Alzoubi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Saidan</surname>
                      <given-names>MN</given-names>
                    </name>
                    <name>
                      <surname>Mubin</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Alorjani</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Mzayek</surname>
                      <given-names>F</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of strict state measures on the epidemiologic curve of covid-19infection in the context of a developing country: a simulation from Jordan</article-title>
                  <source>Int J Environ Res Public Health</source>
                  <year>2020</year>
                  <volume>17</volume>
                  <issue>18</issue>
                  <fpage>6530</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijerph17186530</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <mixed-citation publication-type="other">(2020). URL <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov">https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov</ext-link>)</mixed-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <mixed-citation publication-type="other">Alsinglawi B, Alnajjar F, Mubin O, Novoa M, Alorjani M, Karajeh O, Darwish O (2020) Predicting length of stay for cardiovascular hospitalizations in the intensive care unit: Machine learning approach. In: 2020 42nd annual international conference of the IEEE engineering in medicine biology society (EMBC), pp 5442–5445. 10.1109/EMBC44109.2020.9175889</mixed-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Srinivasu</surname>
                      <given-names>PN</given-names>
                    </name>
                    <name>
                      <surname>SivaSai</surname>
                      <given-names>JG</given-names>
                    </name>
                    <name>
                      <surname>Ijaz</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Bhoi</surname>
                      <given-names>AK</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>JJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Classification of skin disease using deep learning neural networks with MobileNet V2 and LSTM</article-title>
                  <source>Sensors</source>
                  <year>2021</year>
                  <volume>21</volume>
                  <issue>8</issue>
                  <fpage>2852</fpage>
                  <pub-id pub-id-type="doi">10.3390/s21082852</pub-id>
                  <pub-id pub-id-type="pmid">33919583</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
